• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS, S.A. DE C.V. BD SMARTSITE NEEDLE-FREE VALVE; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS, S.A. DE C.V. BD SMARTSITE NEEDLE-FREE VALVE; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 2000EA
Medical Device Problem Code Complete Blockage (1094)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/03/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the bd smartsite needle-free valve experienced occlusion.The following information was provided by the initial reporter: they are occluding and keeping the fluids from running into the patient.
 
Additional Manufacturer Narrative
B.3.Date of event: unknown.The date received by manufacturer has been used for this field.H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that the bd smartsite needle-free valve experienced occlusion.The following information was provided by the initial reporter: they are occluding and keeping the fluids from running into the patient.
 
Additional Manufacturer Narrative
The following fields have been updated due to additional information: d.9.Device available for eval? yes.D.9.Returned to manufacturer on: 01-jun-2023.H.6.Investigation summary: 996 unopened samples (model#: 2000ea, lot#: 23015487) were returned by the customer.It was reported by customer that the bd ea luer lock sites are occluding and keeping the fluids from running into the patient.Evaluation of 59 samples were performed.The sample size quantity was determined per 1701-008-000 swi sample size selection work instruction v.08.The sets were examined for defects and abnormalities.No defects or abnormalities were observed.The samples were connected to a cut off syringe tip to check that the fluid path is in an activated position/open when connected to a syringe.The samples were then attempted to be flushed with water using a 10ml bd syringe to confirm an open fluid path.The fluid paths of 57 of the samples were open and those samples were able to be flushed.The failure was unable to be replicated in these samples.The fluid paths of 2 of the samples were not open and were unable to be flushed.The customer complaint can be verified in these samples.A quality notification was sent to the manufacturer, and samples were sent for further investigation.The manufacturer was able to confirm the failure.Further investigation determined that the potential root cause could be related to the variation of the fluoriosilicone application, although, according to the validation of the process, the technology used allows a number of defective parts due to this condition.A quality alert was created on july 19th, 2023 and communicated by the production supervisor to the involved personnel to reinforce the correct fluorosilicone weighing, and that the operators need to notify to the mechanic and / or manufacturing and quality engineering to correct the problem or in this case, to adjust the amount of fluorosilicone that the machine is applying when the fluorosilicone values are so close to the minimum / or maximum control limits.A device history record review for model: 2000ea, lot number: 23015487 was performed.The search showed that a total of (b)(4) units in 1 lot number was built on 19jan2023.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.This incident has been added to our database of reported incidents.Our business team regularly reviews the collected data for identification of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD SMARTSITE NEEDLE-FREE VALVE
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
phillip emmert
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17013876
Report Number9616066-2023-01022
Device Sequence Number20724438
Product Code FPA
UDI-Device Identifier07613203012751
UDI-Public07613203012751
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
K960280
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date01/18/2026
Device Catalogue Number2000EA
Device Lot Number23015487
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/03/2023
Supplement Date Received by Manufacturer08/07/2023
Initial Report FDA Received Date05/26/2023
Supplement Report FDA Received Date08/22/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/18/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-